Cook Incorporated Asserts Right To Develop New Paclitaxel-Coated Coronary Stent With Guidant Corporation.Business & Health/Medical Editors BLOOMINGTON, Ind.--(BUSINESS WIRE)--Sept. 11, 2001 In response to the delivery of a Notice of Dispute from Boston Scientific The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, Corporation regarding the signing of a series of development and distribution agreements between Cook(R) Incorporated and Guidant Corporation on the development of a paclitaxel-coated coronary stent coronary stent Intracoronary stent Cardiology An expandable tubular device which can be inserted percutaneously, and left within a coronary artery lumen to maintain its patency Pros Clinical and angiographic outcomes are better with intracoronary artery stent , Cook Incorporated issued the following statement: "Cook Incorporated completed a broad review of its contractual obligations under its colicensing agreement with Angiotech Pharmaceuticals Angiotech TSX: ANP is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. for the use of paclitaxel paclitaxel /pac·li·tax·el/ (pak?li-tak´sel) an antineoplastic that promotes and stabilizes polymerization of microtubules, isolated from the Pacific yew tree (Taxus brevifolia); to coat implantable medical devices prior to signing these new distribution and licensing agreements with Guidant," said John DeFord, Ph.D., president and chief executive officer of Cook(R) Incorporated. "After a detailed examination by attorneys and outside legal analysts, we are confident our right to enter into these agreement will withstand any legal challenge." "Guidant Corporation has full confidence in Cook's analysis that Cook was fully within its rights to execute the distribution agreement," said John Capek, Ph.D., president of Guidant Corporation's Vascular Intervention group. With international headquarters in Bloomington, Ind., privately held COOK(R) (www.cookgroup.com/) is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, COOK has been committed to product innovation, skilled hand-craftsmanship and unsurpassed customer satisfaction, earning the company global recognition among medical professionals. Cook Incorporated is acknowledged as an innovator in catheter technology, wire guides, introducer needles and sheaths, stents and stent-grafts, embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun) 1. the process or condition of becoming an embolus. 2. therapeutic introduction of a substance into a vessel in order to occlude it. coils, drainage catheters, tissue-engineered medical biomaterials, vena cava filters Vena Cava Filter Definition A vena cava filter is a device inserted into a major vein to prevent a blood clot from entering the lungs. Purpose , implanted cardiac lead extraction technology and other minimally invasive devices. More than 40 companies in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Europe, Canada, Australia and Asia design, produce, manufacture and distribute COOK brand medical devices to physicians and other medical professionals around the world. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion